Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,025,080,481.29
- Nov. 15, 2024
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 14, 2016 | Director | 6,500 | $92.37 | Sell | $600,405.00 | |
| Sept. 7, 2016 | Director | 6,500 | $95.66 | Sell | $621,790.00 | |
| Aug. 31, 2016 | Director | 6,500 | $94.62 | Sell | $615,030.00 | |
| Aug. 24, 2016 | Director | 7,500 | $100.46 | Sell | $753,450.00 | |
| Aug. 22, 2016 | Director | 1,100 | $100.79 | Sell | $110,869.00 | |
| Aug. 17, 2016 | Director | 6,900 | $99.63 | Sell | $687,447.00 | |
| Aug. 11, 2016 | Director | 900 | $100.19 | Sell | $90,171.00 | |
| Aug. 10, 2016 | Director | 7,100 | $100.24 | Sell | $711,704.00 | |
| Aug. 3, 2016 | Director | 47,000 | $100.66 | Sell | $4,731,020.00 | |
| July 27, 2016 | Director | 6,500 | $95.93 | Sell | $623,545.00 | |
| July 20, 2016 | Director | 6,500 | $90.33 | Sell | $587,145.00 | |
| July 13, 2016 | Director | 6,500 | $88.81 | Sell | $577,265.00 | |
| July 6, 2016 | Director | 5,140 | $88.99 | Sell | $457,408.60 | |
| June 29, 2016 | Director | 5,130 | $84.82 | Sell | $435,126.60 | |
| June 22, 2016 | Director | 5,130 | $86.61 | Sell | $444,309.30 | |
| June 15, 2016 | Director | 5,130 | $91.18 | Sell | $467,753.40 | |
| June 8, 2016 | Director | 5,130 | $94.95 | Sell | $487,093.50 | |
| June 1, 2016 | Director | 5,130 | $93.65 | Sell | $480,424.50 | |
| May 25, 2016 | Director | 5,130 | $89.09 | Sell | $457,031.70 | |
| May 18, 2016 | Director | 5,130 | $81.18 | Sell | $416,453.40 | |
| May 16, 2016 | EVP | 117 | $81.67 | Sell | $9,555.39 | |
| May 16, 2016 | CFO | 202 | $82.06 | Sell | $16,576.12 | |
| May 11, 2016 | Director | 5,130 | $86.50 | Sell | $443,745.00 | |
| May 9, 2016 | SVP | 3,000 | $87.63 | Sell | $262,890.00 | |
| May 4, 2016 | Director | 5,130 | $81.02 | Sell | $415,632.60 | |
| April 27, 2016 | Director | 5,130 | $83.67 | Sell | $429,227.10 | |
| April 20, 2016 | Director | 5,130 | $84.10 | Sell | $431,433.00 | |
| April 13, 2016 | Director | 5,130 | $84.27 | Sell | $432,305.10 | |
| April 6, 2016 | Director | 5,130 | $89.56 | Sell | $459,442.80 | |
| March 30, 2016 | Director | 5,130 | $78.83 | Sell | $404,397.90 | |
| March 23, 2016 | Director | 5,130 | $81.38 | Sell | $417,479.40 | |
| March 16, 2016 | Director | 5,130 | $79.65 | Sell | $408,604.50 | |
| March 2, 2016 | Director | 5,130 | $91.80 | Sell | $470,934.00 | |
| Feb. 24, 2016 | Director | 5,130 | $85.25 | Sell | $437,332.50 | |
| Feb. 17, 2016 | Director | 5,130 | $86.93 | Sell | $445,950.90 | |
| Feb. 10, 2016 | Director | 5,130 | $82.57 | Sell | $423,584.10 | |
| Feb. 3, 2016 | CFO | 12,084 | $90.84 | Sell | $1,097,710.56 | |
| Feb. 3, 2016 | CEO | 9,834 | $90.82 | Sell | $893,123.88 | |
| Feb. 3, 2016 | Director | 5,130 | $90.81 | Sell | $465,855.30 | |
| Feb. 3, 2016 | SVP | 5,062 | $90.82 | Sell | $459,730.84 | |
| Feb. 3, 2016 | EVP | 6,042 | $90.82 | Sell | $548,734.44 | |
| Feb. 2, 2016 | CMO | 2,375 | $91.38 | Sell | $217,027.50 | |
| Jan. 27, 2016 | Director | 11,200 | $93.22 | Sell | $1,044,064.00 | |
| Jan. 20, 2016 | Director | 10,400 | $93.69 | Sell | $974,376.00 | |
| Jan. 13, 2016 | Director | 10,400 | $98.41 | Sell | $1,023,464.00 | |
| Jan. 6, 2016 | Director | 10,400 | $121.96 | Sell | $1,268,384.00 | |
| Jan. 4, 2016 | Director | 1,125 | $122.21 | Sell | $137,486.25 | |
| Dec. 30, 2015 | Director | 10,400 | $127.15 | Sell | $1,322,360.00 | |
| Dec. 21, 2015 | Director | 10,400 | $119.26 | Sell | $1,240,304.00 | |
| Dec. 9, 2015 | Director | 10,400 | $120.80 | Sell | $1,256,320.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Ourania Tatsis, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Elaine Ullian, Bruce Sachs, Stuart A. Arbuckle, Kristen Ambrose, Kenneth L Horton, Wayne Joseph Riley, Megan E Pace, Megan Pace, Jeffrey Leiden, Joy Liu, Thomas Graney, Paul Silva, Christiana Stamoulis, Ian F. Smith, Edward Morrow Atkinson III, Kenneth Horton, Lloyd Carney, Paul M. Silva, Sangeeta N. Bhatia, Jeffrey M. Leiden, Terrence C Kearney, Thomas Connolly, William D Young, and Jonathan Biller
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on Nov. 15, 2024.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.